INTENSITY THERAPEUTICS, INC.(INTS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
INTS Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for INTENSITY THERAPEUTICS, INC. (INTS), a Healthcare sector company. INTS is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of INTS by reported 13-F value include KMT WEALTH MANAGEMENT, Kingsbury Capital Investment Advisors, Sentinus, based on the most recent SEC filings. INTS trades on the Nasdaq exchange and files with the SEC under CIK 1567264. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INTS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for INTENSITY THERAPEUTICS, INC. directly from SEC EDGAR.
Net Income
Q2 2026
$-3.0M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
+28.7% YoYOperating Income
+27.8% YoYEPS (Diluted)
+70.7% YoYTotal Assets
+194.8% YoYOp. Cash Flow
+39.3% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Income | $-11.6M +28.7% | $-16.3M -54.4% | $-10.5M -39.0% | $-7.6M | — |
| Operating Income | $-12.0M +27.8% | $-16.6M -99.4% | $-8.3M -10.2% | $-7.5M | — |
| EPS (Diluted) | $-8.56 +70.7% | $-29.24 -2018.8% | $-1.38 +37.8% | $-2.22 | — |
| Total Assets | $14.1M +194.8% | $4.8M -72.3% | $17.3M +884.3% | $1.8M | — |
| Operating Cash Flow | $-9.2M +39.3% | $-15.2M -111.2% | $-7.2M -31.6% | $-5.5M | — |
Get alerted when INTS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for INTENSITY THERAPEUTICS, INC. including:
Top Institutional Holders of INTS
KMT WEALTH MANAGEMENT, LLC
$2.0M496,493 shKingsbury Capital Investment Advisors LLC
$2.0M496,493 shSentinus, LLC
$109.6K26,723 shVANGUARD CAPITAL MANAGEMENT LLC
$108.9K26,569 shSAPIENT CAPITAL LLC
$106.6K26,006 shNANO CAP NEW MILLENNIUM GROWTH FUND L P
$102.5K25,000 shGEODE CAPITAL MANAGEMENT, LLC
$93.4K22,787 shFNY Investment Advisers, LLC
$90.0K22,000 shMesirow Financial Investment Management, Inc.
$57.9K14,118 shVANGUARD FIDUCIARY TRUST CO
$37.4K9,121 sh
| Fund | Value | Shares |
|---|---|---|
| KMT WEALTH MANAGEMENT, LLC | $2.0M | 496,493 |
| Kingsbury Capital Investment Advisors LLC | $2.0M | 496,493 |
| Sentinus, LLC | $109.6K | 26,723 |
| VANGUARD CAPITAL MANAGEMENT LLC | $108.9K | 26,569 |
| SAPIENT CAPITAL LLC | $106.6K | 26,006 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $102.5K | 25,000 |
| GEODE CAPITAL MANAGEMENT, LLC | $93.4K | 22,787 |
| FNY Investment Advisers, LLC | $90.0K | 22,000 |
| Mesirow Financial Investment Management, Inc. | $57.9K | 14,118 |
| VANGUARD FIDUCIARY TRUST CO | $37.4K | 9,121 |
More Healthcare Companies
View all Healthcare →Put INTS on your watchlist
Track score changes the day INTENSITY THERAPEUTICS, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is INTS a good stock to buy?
13F Pro's AI-powered analysis of INTENSITY THERAPEUTICS, INC. (INTS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for INTS are available on the INTS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. INTS is classified as a small company.
Which hedge funds own INTS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling INTS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of INTENSITY THERAPEUTICS, INC.'s investment landscape.